Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 2,338 | 1,973 | 214 |
| Receivables | 1,129 | 57 | 72 |
| Inventories | 430 | N/A | N/A |
| Other current assets | 72 | 31 | 29 |
| TOTAL | $4,278 | $2,487 | $657 |
| Non-Current Assets | |||
| PPE Net | 56 | 95 | 3 |
| TOTAL | $56 | $95 | $3 |
| Total Assets | $4,334 | $2,582 | $660 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 527 | 27 | 0 |
| Accrued Expenses | 384 | 409 | 216 |
| Other current liabilities | 6,992 | 661 | 317 |
| TOTAL | $7,940 | $1,131 | $533 |
| Non-Current Liabilities | |||
| TOTAL | $1 | $38 | $0 |
| Total Liabilities | $7,941 | $1,169 | $533 |
| Shareholders' Equity | |||
| Retained earnings | -14,563 | -4,610 | -1,275 |
| TOTAL | $-3,607 | $1,413 | $127 |
| Total Liabilities And Equity | $4,334 | $2,582 | $660 |